Hydrofarm Holdings Group, Inc. filed a Form 8-K on October 27, 2026, disclosing the closing of a registered direct offering and concurrent private placement that generated gross proceeds of $8.3 million.

Key Highlights

  • Gross proceeds: The company received $8.3 million on the October 27, 2026 closing date, before deducting offering expenses and placement agent fees, according to the filing.
  • Shares issued: 1,599,400 registered shares were sold in the direct offering and 6,971,575 unregistered shares in the concurrent private placement, both at $0.905 per share.
  • Pre-funded warrants: Pre-funded warrants to purchase up to 640,000 shares were issued at a purchase price of $0.9049 per share and an exercise price of $0.0001 per share.
  • Common warrants: Investors received common warrants to purchase an aggregate of 9,210,975 shares at an exercise price of $0.78 per share, exercisable immediately and expiring 5.5 years from the issue date.
  • Placement agent: ThinkEquity LLC served as exclusive placement agent, receiving a cash fee equal to 8% of the aggregate purchase price plus reimbursement of expenses up to $125,000.
  • Lock-up period: Certain directors, executive officers, and 10% or greater stockholders entered lock-up agreements restricting transactions for 120 days following the effective date defined in the Purchase Agreement.
  • Use of proceeds: The company disclosed it will use proceeds from the offering for general corporate purposes.

Hydrofarm's October 2026 Capital Raise: Structure and Key Terms

According to the filing, Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) entered into a securities purchase agreement on October 27, 2026, with certain institutional investors covering two simultaneous components. In the registered direct offering, the company sold 1,599,400 shares of common stock at $0.905 per share under its shelf registration statement on Form S-3 (File No. 333-291444), which the SEC declared effective on December 10, 2025. A concurrent private placement, conducted under the exemption in Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D, covered 6,971,575 additional shares at the same price per share.

The filing also discloses that pre-funded warrants to purchase up to 640,000 shares were issued at $0.9049 per share, with an exercise price of $0.0001. For no additional consideration, each investor received common warrants equal to 100% of their respective shares and pre-funded warrants, totaling 9,210,975 common warrant shares at an exercise price of $0.78 per share. The common warrants are immediately exercisable and expire 5.5 years from issuance. The filing notes that warrant holders may not exercise if doing so would result in beneficial ownership exceeding 4.99% (or 9.99% upon holder election) of outstanding common stock.

In connection with the offering, the company entered into a registration rights agreement obligating it to file a resale registration statement within 15 calendar days and to use reasonable best efforts to have it declared effective within 45 calendar days (or 75 calendar days in the event of a full SEC review). The filing states that failure to meet certain registration obligations may require the company to pay partial liquidated damages in cash equal to 2.0% of the aggregate subscription amount paid by each affected holder on the date of such failure and on each monthly anniversary thereafter until the failure is cured, prorated for partial months. The placement agent, ThinkEquity LLC, also received common warrants equal to 8% of shares and pre-funded warrants sold, exercisable from issuance and expiring October 27, 2031, with an exercise price of $0.78.

What Was Disclosed

The filing reports the October 27, 2026 closing of a combined registered direct offering and private placement by Hydrofarm Holdings Group, Inc., generating $8.3 million in gross proceeds. Related agreements covering registration rights, lock-up obligations, escrow, and placement agency were also disclosed.